898 results match your criteria: "Proteus Syndrome"
Am J Med Genet A
December 2024
Constitutional Genetics Laboratory, CHU Amiens Picardie, Amiens, France.
Proteus syndrome (PS) is a rare disorder (< 1/1000000), marked by progressive overgrowth commonly impacting the skeleton, skin, adipose tissue, and central nervous system. Clinical criteria were established in 2019. PS arises from a somatic activating variation in the AKT1 gene.
View Article and Find Full Text PDFJ Med Genet
December 2024
Center for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA
-related Proteus syndrome is an ultra-rare mosaic overgrowth disorder with tumour predisposition. We conducted a systematic review to determine the range and characteristics of these tumours. A systematic review was conducted to identify clinical reports and clinical series of Proteus syndrome published between 1983 and 2023.
View Article and Find Full Text PDFAsian J Surg
December 2024
Department of Neurosurgery, Sanbo Brain Hospital, Beijing, China. Electronic address:
J Am Podiatr Med Assoc
November 2024
*Department of Orthopaedics and Traumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Background: Proteus syndrome is a rare disorder characterized by overgrowth of limbs and organs and neurocutaneous findings.
Methods: We examined three Proteus syndrome cases with unilateral foot enlargement, megafoot. The patients had ambulatory and cosmetic difficulties.
Childs Nerv Syst
December 2024
Department of Neurological Surgery, New Jersey Pediatric Neuroscience Institute, 131 Madison Ave 3rd Floor, Morristown, NJ, 07960, USA.
BMJ Case Rep
September 2024
Department of Internal Medicine, Kantonsspital Graubünden, Chur, Graubünden, Switzerland
Heliyon
August 2024
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Objective: Proteus syndrome, a rare disorder with an incidence of one in a million, is characterized by connective tissue nevi, asymmetric limb overgrowth, and abnormal subcutaneous adipose tissue distribution. Limited awareness of this condition often hinders accurate clinical diagnosis. We report a case of Proteus syndrome with concurrent progressive paralysis in the unilateral lower limb, aiming to enhance understanding of the disease and its associated complications.
View Article and Find Full Text PDFCurr Top Microbiol Immunol
August 2024
Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
S Afr Med J
May 2024
Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Arch Plast Surg
July 2024
Malopolska Burn and Plastic Surgery Center, Ludwik Rydygier Memorial Hospital in Krakow, Cracow, Poland.
Ann Endocrinol (Paris)
June 2024
CHU Lille, Endocrinology, Diabetology and Metabolism, 59000 Lille, France; University Lille, 59000 Lille, France; Inserm U1190, 59000 Lille, France; Competence center PRISIS, Endocrinology and Metabolism Department, CHU, Lille, France. Electronic address:
Cureus
May 2024
Radiodiagnosis, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, IND.
Indian Dermatol Online J
April 2024
Department of Radiodiagnosis, ABVIMS and Dr. RML Hospital, New Delhi, Delhi, India.
International Society for the Study of Vascular Anomalies classification defines Congenital Limb Overgrowth Vascular Syndromes (CLOS) as a subset of vascular syndromes with other abnormalities that present with unilateral limb overgrowth. It includes Klippel-Trenaunay Syndrome, Parkes-Weber Syndrome, CLOVES (Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, Spinal/Skeletal Anomalies/Scoliosis) Syndrome, Proteus Syndrome, PTEN Hamartomatous Syndrome, and Fibroadipose Vascular Anomaly. Due to their rare and complex nature, a multidisciplinary approach to diagnosis and treatment is required.
View Article and Find Full Text PDFFront Med (Lausanne)
May 2024
Department of Anesthesiology, Critical Care Medicine and Emergency, Department of Innovative Technologies in Medicine and Dentistry, "G. d'Annunzio" University Chieti-Pescara, Chieti, Italy.
Medicina (Kaunas)
May 2024
Department of Molecular Sciences, Faculty of Medicine, University of Medicine and Pharmacy "Iuliu Hațieganu", 400012 Cluj-Napoca, Romania.
Int J Dermatol
August 2024
Department of Dermatology, University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Brazil.
Front Neurol
April 2024
Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
bioRxiv
January 2024
Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Orphanet J Rare Dis
February 2024
Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
J AAPOS
February 2024
Department of Ophthalmology, Children's Health Ireland, Dublin.
Iran J Otorhinolaryngol
November 2023
Second ΕΝΤ Department, School of Medicine, "Attikon" University Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Eur Rev Med Pharmacol Sci
November 2023
Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Clin Case Rep
October 2023
Department of Otorhinolaryngology, Head and Neck Surgery University of Heidelberg Heidelberg Germany.
Jt Dis Relat Surg
August 2023
Afyonkarahisar Sağlık Bilimleri Üniversitesi, Ortopedi ve Travmatoloji Anabilim Dalı, 03200 Afyonkarahisar, Türkiye.
Postepy Dermatol Alergol
August 2023
Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.